Download PDF
Planta Med 2015; 81(12/13): 968-974
DOI: 10.1055/s-0035-1545879
Reviews
Georg Thieme Verlag KG Stuttgart · New York

A Valuable Option for the Treatment of Respiratory Diseases: Review on the Clinical Evidence of the Ivy Leaves Dry Extract EA 575®[*]

Christopher Lang
Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany
,
Patricia Röttger-Lüer
Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany
,
Christiane Staiger
Engelhard Arzneimittel GmbH & Co. KG, Niederdorfelden, Germany
› Author Affiliations
Further Information

Publication History

received 12 January 2015
revised 16 February 2015

accepted 28 February 2015

Publication Date:
15 April 2015 (online)

Also available at
   Permissions and Reprints

Abstract

Preparations from ivy leaves (Hederae helicis folium, Hedera helix) dry extracts are well established in the treatment of different respiratory diseases. Until today, the efficacy and safety of ivy leaf preparations has been demonstrated in a variety of controlled clinical studies and non-interventional studies. These results were nearly exclusively obtained using the commercial ivy leaves dry extract EA 575®. This paper will provide information on the clinical data obtained with this special extract, showing the importance of those preparations as a valuable therapeutic option for the treatment of acute and chronic respiratory diseases. Overall, 18 publications covering clinical trials and non-interventional studies of, in total, 65 383 patients suffering from acute as well as chronic respiratory diseases were included.

Key words

Hedera helix - Araliaceae - ivy - clinical trial - non-interventional study - efficacy - safety

* Dedicated to Professor Dr. Dr. h. c. mult. Adolf Nahrstedt on the occasion of his 75th birthday.


 

  • References

  • 1 Mayer H, Pfandl A, Grigorieff A, Zickner I. Der Efeu – eine alte Kult- und Heilpflanze. Pharm Ztg 1987; 138: 2673-2676
    PubMedSearch in Google Scholar
  • 2 Landgrebe H, Matusch R, Runkel F, Hecker M. Wirkung und Anwendung einer Heilpflanze. Pharm Ztg 1999; 144: 11-15
    PubMedSearch in Google Scholar
  • 3 Stauss-Grabo M, Atiye S. Efeu – eine traditionelle Heilpflanze in der modernen Phytotherapie. Z Phytother 2009; 30: 289-291
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 The Committee on Herbal Medicinal Products. Assessment report on Hedera helix L., folium. 2011. EMA/HMPC/289432/2009. Available online at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2012/01/WC500120648.pdf Accessed March 20, 2015
    PubMed
  • 5 The Committee on Herbal Medicinal Products. Community herbal monograph on Hedera helix L., folium. 2011. EMA/HMPC/289430/2009. Available online at http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2011/04/WC500105313.pdf Accessed March 20, 2015
    PubMed
  • 6 ESCOP Monographs. The scientific foundation for herbal medicinal products. 2nd. edition. European Scientific Cooperative on Phytotherapy. Hederae helicis folium, ivy leaf. Stuttgart: Thieme Verlag; 2003: 241-247
    Search in Google Scholar
  • 7 Hiller K, Willuhn G, Loew D. Hederae folium – Efeublätter. In: Wichtl M, editor Teedrogen und Phytopharmaka. Ein Handbuch für die Praxis auf wissenschaftlicher Grundlage, 5th edition. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2009: 328-330
    Search in Google Scholar
  • 8 Trute A, Gross J, Mutschler E, Nahrstedt A. In vitro antispasmodic compounds of the dry extract obtained from Hedera helix . Planta Med 1997; 63: 125-129
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Hegener O, Prenner L, Runkel F, Baader SL, Kappler J, Häberlein H. Dynamics of β2-adrenergic receptor-ligand complexes on living cells. Biochemistry 2004; 43: 6190-6199
    CrossrefPubMedSearch in Google Scholar
  • 10 Runkel F, Prenner L, Häberlein H. In-vitro Studien: Ein Beitrag zum Wirkmechanismus von Efeu. Pharm Ztg 2005; 150: 19-25
    PubMedSearch in Google Scholar
  • 11 Sieben A, Prenner L, Sorkalla T, Wolf A, Jakobs D, Runkel F, Häberlein H. α-Hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behaviour, dynamics, and regulation of β2-adrenergic receptors. Biochemistry 2009; 48: 3477-3482
    CrossrefPubMedSearch in Google Scholar
  • 12 Wolf A, Gosens R, Meurs H, Häberlein H. Pre-treatment with α-hederin increases β-adrenoceptor mediated relaxation of airway smooth muscle. Phytomedicine 2011; 18: 214-218
    CrossrefPubMedSearch in Google Scholar
  • 13 Greunke C, Hage-Hülsmann A, Sorkalla T, Keksel N, Häberlein F, Häberlein H. A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the β 2-adrenergic responsiveness of human airway smooth muscle cells. Pulm Pharmacol Ther advance online publication 16 September 2014
    PubMed
  • 14 Gaedcke F, Steinhoff B. Phytopharmaka. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 2000
    Search in Google Scholar
  • 15 Blume H, Brauer KG, Dingermann T, Mutschler E, Steinhilber D, Abdel-Tawab M, Zündorf I. Leitlinie Gute Substitutionspraxis der Deutschen Pharmazeutischen Gesellschaft. Available at http://www.dphg.de/fileadmin/content/pdfs/dphg_leitlinie_gute_substitutionspraxis.pdf Accessed January 06, 2015
    PubMed
  • 16 Criée CP, Berdel D, Heise D, Kardos P, Köhler D, Leupold W, Magnussen H, Marek W, Merget R, Mitfessel H, Rolke M, Sorichter S, Worth H, Wuthe H. Empfehlungen der Deutschen Atemwegsliga zur Spirometrie. Oberhaching: Dustri-Verlag Dr. Karl Feistle; 2006
    Search in Google Scholar
  • 17 Criée CP, Berdel D, Heise D, Jörres RA, Kardos P, Köhler D, Leupold W, Magnussen H, Marek W, Merget R, Mitfessel H, Raschke K, Rolke M, Smith HJ, Sorichter S, Worth H. Empfehlungen zur Ganzkörperplethysmographie (Bodyplethysmographie). Oberhaching: Dustri-Verlag Dr. Karl Feistle; 2009
    Search in Google Scholar
  • 18 Meyer-Wegener J, Liebscher K, Hettich M, Kastner HG. Efeu versus Ambroxol bei chronischer Bronchitis. Z Allg Med 1993; 69: 61-66
    PubMedSearch in Google Scholar
  • 19 Maidannik V, Duka E, Kachalova O, Efanova A, Svoykina S, Sosnovskaja T. Efficacy of Prospan application in childrenʼs disease of respiratory tract. Pediatr Tocol Gyn 2003; 4: 1-7
    PubMedSearch in Google Scholar
  • 20 Bolbot Y, Prokhorov E, Mokia S, Yurtseva A. Comparing the efficacy and safety of high-concentrate (5–7.5: 1) ivy leaves extract and acetylcysteine for treatment of children with acute bronchitis. Drugs of Ukraine 2004; 11: 1-4
    PubMedSearch in Google Scholar
  • 21 Mansfeld HJ, Höhre H, Repges R, Dethlefsen U. Therapy of bronchial asthma with dried ivy leaf extract. Münch Med Wschr 1998; 140: 26-30
    PubMedSearch in Google Scholar
  • 22 Zeil S, Schwanebeck U, Vogelberg C. Tolerance and effect of an add-on treatment with a cough medicine containing ivy leaves dry extract on lung function in children with bronchial asthma. Phytomedicine 2014; 21: 1216-1220
    CrossrefPubMedSearch in Google Scholar
  • 23 Gulyas A, Repges R, Dethlefsen U. Consequent therapy of chronic obstructive respiratory tract illnesses in children. Atemw Lungenkrkh 1997; 5: 291-294
    PubMedSearch in Google Scholar
  • 24 Mansfeld HJ, Höhre H, Repges R, Dethlefsen U. Sekretolyse und Spasmolyse. TW Pädiatrie 1997; 10: 155-157
    PubMedSearch in Google Scholar
  • 25 Unkauf M, Friedrich M. Bronchitis bei Kindern – Klinische Studie mit Efeublätter-Trockenextrakt. Der Bayerische Internist 2000; 4: 1-4
    PubMedSearch in Google Scholar
  • 26 Cwientzek U, Ottillinger B, Arenberger P. Acute bronchitis therapy with ivy leaves extracts in a two-arm study. A double-blind, randomized study vs. an other ivy leaves extract. Phytomedicine 2011; 18: 1105-1109
    CrossrefPubMedSearch in Google Scholar
  • 27 Gulyas A, Lämmlein MM. The treatment of chronic obstructive bronchitis in children. Sozialpädiatrie 1992; 14: 632-634
    PubMedSearch in Google Scholar
  • 28 Lässig W, Generlich H, Heydolph F, Paditz E. Wirksamkeit und Verträglichkeit efeuhaltiger Hustenmittel. TW Pädiatrie 1996; 9: 489-491
    PubMedSearch in Google Scholar
  • 29 Hecker M. Wirksamkeit und Verträglichkeit von Efeuextrakt bei Patienten mit Atemwegserkrankungen. Natura Med 1999; 14: 28-33
    PubMedSearch in Google Scholar
  • 30 Hecker M, Runkel F, Völp A. Behandlung chronischer Bronchitits mit einem Spezialextrakt aus Efeublättern – multizentrische Anwendungsbeobachtung mit 1350 Patienten. Forsch Komplementärmed Klass Naturheilkd 2002; 9: 77-84
    CrossrefPubMedSearch in Google Scholar
  • 31 Kraft K. Verträglichkeit von Efeublättertrockenextrakt im Kindesalter. Z Phytother 2004; 25: 179-181
    PubMedSearch in Google Scholar
  • 32 Fazio S, Pouso J, Dolinsky D, Fernandez A, Hernandez M, Clavier G, Hecker M. Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicenter postmarketing study in 9657 patients. Phytomedicine 2009; 16: 17-24
    CrossrefPubMedSearch in Google Scholar
  • 33 Stauss-Grabo M, Atiye S, Warnke A, Wedemeyer RS, Donath F, Blume HH. Observational study on the tolerability and safety of film-coated tablets containing ivy extract (Prospan® Cough Tablets) in the treatment of colds accompanied by coughing. Phytomedicine 2011; 18: 433-436
    CrossrefPubMedSearch in Google Scholar
  • 34 Beden AB, Perko J, Terčelj R, Kreft S. Treatment of acute respiratory infections in Slovenian children with ivy leaf extract syrup. Zdrav Vestn 2011; 80: 276-284
    PubMedSearch in Google Scholar
  • 35 Kraft K, Enzel U. Einsatz von Phytopharmaka bei Kindern. Indikationen, Möglichkeiten, Grenzen. Pädiat Prax 2013; 80: 695-704
    PubMedSearch in Google Scholar
  • 36 Hofmann D, Hecker M, Völp A. Efficacy of dry extract of ivy leaves in children with bronchial asthma – a review of randomized controlled trials. Phytomedicine 2003; 10: 213-220
    CrossrefPubMedSearch in Google Scholar
  • 37 Veit M. Gleiche Quelle, gleiche Wirkung?. Dtsch Apoth Ztg 2014; 33: 3518-3523
    PubMedSearch in Google Scholar